<DOC>
	<DOCNO>NCT01207414</DOCNO>
	<brief_summary>Evaluate clinical outcome two switch strategy iloperidone treatment adult subject schizophrenia require change current antipsychotic treatment risperidone , olanzapine , aripiprazole due suboptimal efficacy and/or safety/tolerability reason .</brief_summary>
	<brief_title>Switching Iloperidone From Other Antipsychotics Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Males female , 18 64 year age , inclusive DSMIV diagnosis schizophrenia Patients currently optimal inlabel dose one follow permit antipsychotic treatment least 30 day : risperidone , olanzapine , aripiprazole Efficacy Clinical Global Impression Severity ( ECGIS ) 4 5 Not tolerate one permitted treatment exhibit one allowable sideeffects Any current Axis I disorder schizophrenia focus treatment ; Acutely psychotic patient 's symptom severity require hospitalization Patient significant cardiovascular illness ( myocardial infarction , cardiac arrhythmia ) Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>iloperidone</keyword>
	<keyword>switch</keyword>
	<keyword>gradual switch</keyword>
	<keyword>immediate switch</keyword>
</DOC>